The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain
- PMID: 9842827
The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain
Abstract
The management of patients with neuropathic pain is challenging. There are only a few reports regarding the acute effects of the commonly used adjuvant drugs amitriptyline (AMI), gabapentin (GBP), and lidocaine (LDC) on neuropathic pain behaviors in animal models. Thus, the purpose of this study was to investigate the acute effects of AMI, GBP, and LDC on behavioral signs of mechanical allodynia and the site of action of these drugs using a rat model of neuropathic pain. Under general anesthesia with halothane, neuropathic injury was produced in rats by tightly ligating the left L5 and L6 spinal nerves. In Experiment 1, baseline mechanical allodynia data were recorded, and the animals were randomly divided into five groups: Group 1 received saline intraperitoneally (IP), Group 2 received AMI (1.5 mg/kg IP); Group 3 received GBP (50 mg/kg IP), Group 4 received an IV saline infusion for 10 min, and Group 5 received LDC (10-mg/kg IV infusion) for 10 min. Measurements of mechanical allodynia were repeated 0.5, 1, 2, and 4 h and 1, 3, and 7 days after treatment. In Experiment 2, rats were prepared similarly to the first experiment, and a single unit activity of continuous discharges of injured afferent fibers was recorded from the left L5 fascicles before and until 1 h after treatment. All animals developed neuropathic pain behavior within 7 days after surgery. All three tested drugs were effective in increasing the threshold for mechanical allodynia as early as 30 min after treatment, and the effect lasted for at least 1 h. Furthermore, AMI and LDC reduced the rate of continuing discharges of injured afferent fibers, whereas GBP did not influence these discharges. Our findings clearly demonstrate an attenuation of neuropathic pain behavior in rats treated with AMI, GBP, or LDC. Finally, the site of action of LDC seems to be primarily in the periphery, and that of GBP is exclusively central, whereas that of AMI seems to have both peripheral and central components.
Implications: In the present study, we examined the effectiveness of three drugs commonly used for the treatment of neuropathic pain. Systemic injections of amitriptyline, gabapentin, or lidocaine produced pain-relieving effects in this established model for neuropathic pain in rats, which supports their clinical use in managing patients with neuropathic pain syndromes.
Similar articles
-
Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.Brain Res. 2004 Aug 27;1018(2):159-70. doi: 10.1016/j.brainres.2004.05.058. Brain Res. 2004. PMID: 15276874
-
The effect of amitriptyline on ectopic discharge of primary afferent fibers in the L5 dorsal root in a rat model of neuropathic pain.Anesth Analg. 2009 May;108(5):1671-9. doi: 10.1213/ane.0b013e31819b0271. Anesth Analg. 2009. PMID: 19372353
-
A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury.Br J Pharmacol. 2004 Jan;141(1):65-74. doi: 10.1038/sj.bjp.0705596. Epub 2003 Dec 8. Br J Pharmacol. 2004. PMID: 14662726 Free PMC article.
-
Use of gabapentin in the treatment of neuropathic pain.Ann Pharmacother. 2000 Jun;34(6):802-7. doi: 10.1345/aph.19303. Ann Pharmacother. 2000. PMID: 10860142 Review.
-
Diagnosis and management of neuropathic pain: a balanced approach to treatment.J Am Acad Nurse Pract. 2003 Dec;15(12 Suppl):3-9. J Am Acad Nurse Pract. 2003. PMID: 15055383 Review.
Cited by
-
Prevention of persistent pain with lidocaine infusions in breast cancer surgery (PLAN): study protocol for a multicenter randomized controlled trial.Trials. 2024 May 22;25(1):337. doi: 10.1186/s13063-024-08151-4. Trials. 2024. PMID: 38773653 Free PMC article.
-
Mechanisms and treatments of neuropathic itch in a mouse model of lymphoma.J Clin Invest. 2023 Feb 15;133(4):e160807. doi: 10.1172/JCI160807. J Clin Invest. 2023. PMID: 36520531 Free PMC article.
-
Intravenous Lidocaine for Treatment of Chronic Pain: A Retrospective Cohort Study.J Pain Res. 2022 Oct 28;15:3459-3467. doi: 10.2147/JPR.S379208. eCollection 2022. J Pain Res. 2022. PMID: 36329833 Free PMC article.
-
Deep Learning Classification of Treatment Response in Diabetic Painful Neuropathy: A Combined Machine Learning and Magnetic Resonance Neuroimaging Methodological Study.Neuroinformatics. 2023 Jan;21(1):35-43. doi: 10.1007/s12021-022-09603-5. Epub 2022 Aug 26. Neuroinformatics. 2023. PMID: 36018533 Free PMC article.
-
Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial.Trials. 2019 Jan 15;20(1):49. doi: 10.1186/s13063-018-3169-3. Trials. 2019. PMID: 30646965 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous